CBA Florida Inc. (fka CBAI)

[biglove]

$15 Billion Worldwide Market projected by 2015
[url][/url][tag]http://www.prlog.org/10453315-global-cord-blood-stem-cells-market-to-hit-us15-billion-by-2015.html[/tag]
Unfortunately, the full report costs $4300!
Here is the Summary:
Summary

Umbilical cord and placenta, once considered medical waste are emerged to be a valuable source of stem cells. The cord blood stem cells show the potential to treat the fatal diseases such as leukemia, cardiac attacks and debilitating diseases including Alzheimer's and Parkinson's. Cord blood stem cells are also widely used in therapies such as blood disorders, bone and tissue engineering, dermatology.

Cord blood stem cell technologies analyzed in this study include Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant. The report is also analyses the global market for stem cell therapeutic areas comprising Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other.

Global cord blood stem cells market for 2010 is estimated at about US$4.5 billion. The market is further projected to register a robust CAGR of 27.3% during the period 2006-2015 to reach US$15 billion by 2015. The study includes 129 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments.

The report analyses the cord blood stem cells market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 21 independent countries across Europe - The United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe; North America - the United States, Canada and Mexico; Asia-Pacific - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific; Rest of World - Brazil, Columbia, Argentina and Israel.

This study profiles 47 key global players and 63 major players across North America - 33; Europe - 10; Asia-Pacific - 15; and Rest of World - 5. The report also provides the listing of the companies engaged in collection, processing and banking of cord blood stem cells. This list also includes the companies engaged in the treatment of deadly diseases using CB stem cells. The global list covers the addresses, contact numbers and the website addresses of 219 private and 75 public cord blood banks.